High Rate of Virological Response to Peginterferon α-2a–Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C

BACKGROUND: Hepatitis C is a major reason of morbidity and mortality among hemophilia patients. Although combination therapy with peginterferon (peg-INF) and ribavirin is considered as standard treatment for chronic hepatitis C (CHC), but more evidence of the efficacy and safety is needed. OBJECTIVE...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Alavi Moghaddam, Mostafa, Zali, Mohammad Reza, Aalaei Andabili, Seyed Hossein, Derakhshan, Faramarz, Miri, Seyed Mohammad, Alavian, Seyed Moayed
Формат: Artigo
Язык:Inglês
Опубликовано: Kowsar 2012
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3470839/
https://ncbi.nlm.nih.gov/pubmed/23105981
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы